U.S. Government Shutdown Drags On: What’s Next? 🏛️💸
The U.S. government shutdown continues as Senate rejects funding, risking health costs and federal worker pay. Will it stretch into November? 🏛️💼
Healthcare
Read More
China Ranks 2nd in Global Drug Innovation 🚀💊
China now ranks second globally in new drug development, with over 20% of global research happening domestically. A game-changer for healthcare innovation. 💊🌍
From Rubble to Revival: Wuhan Hospital’s Century of Resilience 🏥✨
From wartime ruins to a medical powerhouse: How Wuhan’s Renmin Hospital became a symbol of resilience and innovation. 🏥🌍
China’s Nuclear Breakthrough: Yttrium-90 Now Made in Commercial Reactors 🎯⚛️
China’s new method to produce Yttrium-90 in commercial reactors could revolutionize liver cancer treatments. 🎯⚛️ #NuclearTech #Healthcare
Roberta Lipson: 40+ Years Shaping China’s Healthcare 🌏🏥
NY-born Roberta Lipson revolutionized China’s healthcare over 40+ years, introducing cutting-edge tech and fostering global youth exchanges. 🏥🌍
China’s Healthcare Payment Reforms Ease Access for Millions 💉🌍
China’s new medical payment system streamlines cross-regional care, easing financial burdens for patients and hospitals. 💊 #HealthcareReform
Prostate Cancer Surge: Experts Push PSA Screening for Men Over 50 ✅
As prostate cancer cases rise globally, experts urge men over 50 to get regular PSA screenings for early detection. Learn why timely checks save lives. 🌍🔍
Lung Cancer Tops Global Deaths for 10 Years: What You Need to Know 🌍🚭
Lung cancer remains the leading cause of global cancer deaths for a decade. Learn about prevention, screening, and the latest data from health experts. 🌍💔 #HealthAlert
Lenovo’s Fire Seed Project: Humanoid Robots Set to Transform Healthcare & Education
Lenovo’s Fire Seed Project is advancing humanoid robotics with partners like Zhongke Huiling, aiming to transform industries such as healthcare and education. 🤖🌟
Breakthrough in Parkinson’s Treatment: Chinese Scientists Discover Key Target 🧠💊
Chinese researchers discover FAM171A2, a new therapeutic target for Parkinson’s disease with potential to slow its progression. 🧪💡